4//SEC Filing
Stangl Rolf 4
Accession 0000950170-25-048211
CIK 0001527508other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 12:08 PM ET
Size
6.9 KB
Accession
0000950170-25-048211
Insider Transaction Report
Form 4
Stangl Rolf
Director
Transactions
- Award
Common Stock
2025-04-01+161→ 91,766 total - Disposition to Issuer
Common Stock
2025-04-01−91,766→ 0 total
Footnotes (3)
- [F1]Represents additional shares acquired by the reporting person in connection with the settlement of dividend equivalent rights upon the accelerated vesting of the reporting person's outstanding restricted stock units ("RSUs"), as described below.
- [F2]On April 1, 2025, pursuant to the Agreement and Plan of Merger dated as of December 9, 2024 (the "Merger Agreement"), by and among the Issuer, Novolex Holdings, LLC (the "Parent") and Alpha Lion Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of the Parent.
- [F3]Pursuant to the Merger Agreement, each share of the Issuer's common stock and each unvested RSU, including any dividend equivalent rights accrued thereon, was canceled and converted into the right to receive $18.00 in cash, without interest.
Documents
Issuer
Pactiv Evergreen Inc.
CIK 0001527508
Entity typeother
Related Parties
1- filerCIK 0001823910
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 12:08 PM ET
- Size
- 6.9 KB